Efficacy of Bravecto
Aelurostrongylus abstrusus
Control
Feline lungworms
Macrocyclic lactones
Moxidectin
Prevention
Treatment
Journal
Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774
Informations de publication
Date de publication:
16 Feb 2021
16 Feb 2021
Historique:
received:
20
11
2020
accepted:
23
01
2021
entrez:
17
2
2021
pubmed:
18
2
2021
medline:
4
9
2021
Statut:
epublish
Résumé
The feline lungworm Aelurostrongylus abstrusus affects the lower respiratory tract in cats worldwide. As infections may lead to chronic respiratory changes or even death, preventive treatment in cats with outdoor access is warranted. The preventive efficacy of a spot-on solution (Bravecto® Plus spot-on solution for cats, MSD) against cat aelurostrongylosis was evaluated using three different preventive treatment regimes in a negative controlled, randomized and partially blinded laboratory efficacy study with 31 purposed-bred cats. The minimum recommended dose of 2.0 mg moxidectin + 40 mg fluralaner/kg bodyweight was applied once 12 (Group [G]1), 8 (G2) or 4 (G3) weeks before experimental infection with 300 third-stage larvae (L3) of A. abstrusus. Another group served as untreated control (G4). Individual faecal samples were analysed as of day 30 post infection (pi) to monitor larvae excretion. Necropsy was performed at days 47-50 pi. The lungs were examined macroscopically for pathological findings and (pre-)adult worms were counted to assess preventive efficacy. Beginning at day 32-40 pi, all cats of the control group were constantly shedding larvae of A. abstrusus, whereas only one animal of G1 excreted larvae at several consecutive days. In addition, two cats of G1 and G3 and three of G2 were positive on a single occasion. The geometric mean (GM) of the maximum number of excreted larvae was 7574.29 in the control group compared to 1.10 (G1), 1.19 (G2) and 0.53 (G3), resulting in a GM reduction of > 99.9% in all treatment groups. All lungs of the control animals showed severe or very severe alterations at necropsy, while in 94.44% of the treated cats lung pathology was rated as absent or mild. The GM number of (pre-)adult A. abstrusus retrieved from the lungs was 26.57 in the control group, 0.09 in G1 and 0.00 in G2 and G3. Thus, GM worm count reduction was 99.66% in G1 and 100% in G2 and G3. A single application of Bravecto® Plus spot-on solution at a dose of 2.0 mg moxidectin + 40 mg fluralaner/kg bodyweight reliably prevents cat aelurostrongylosis for at least 12 weeks.
Sections du résumé
BACKGROUND
BACKGROUND
The feline lungworm Aelurostrongylus abstrusus affects the lower respiratory tract in cats worldwide. As infections may lead to chronic respiratory changes or even death, preventive treatment in cats with outdoor access is warranted.
METHODS
METHODS
The preventive efficacy of a spot-on solution (Bravecto® Plus spot-on solution for cats, MSD) against cat aelurostrongylosis was evaluated using three different preventive treatment regimes in a negative controlled, randomized and partially blinded laboratory efficacy study with 31 purposed-bred cats. The minimum recommended dose of 2.0 mg moxidectin + 40 mg fluralaner/kg bodyweight was applied once 12 (Group [G]1), 8 (G2) or 4 (G3) weeks before experimental infection with 300 third-stage larvae (L3) of A. abstrusus. Another group served as untreated control (G4). Individual faecal samples were analysed as of day 30 post infection (pi) to monitor larvae excretion. Necropsy was performed at days 47-50 pi. The lungs were examined macroscopically for pathological findings and (pre-)adult worms were counted to assess preventive efficacy.
RESULTS
RESULTS
Beginning at day 32-40 pi, all cats of the control group were constantly shedding larvae of A. abstrusus, whereas only one animal of G1 excreted larvae at several consecutive days. In addition, two cats of G1 and G3 and three of G2 were positive on a single occasion. The geometric mean (GM) of the maximum number of excreted larvae was 7574.29 in the control group compared to 1.10 (G1), 1.19 (G2) and 0.53 (G3), resulting in a GM reduction of > 99.9% in all treatment groups. All lungs of the control animals showed severe or very severe alterations at necropsy, while in 94.44% of the treated cats lung pathology was rated as absent or mild. The GM number of (pre-)adult A. abstrusus retrieved from the lungs was 26.57 in the control group, 0.09 in G1 and 0.00 in G2 and G3. Thus, GM worm count reduction was 99.66% in G1 and 100% in G2 and G3.
CONCLUSIONS
CONCLUSIONS
A single application of Bravecto® Plus spot-on solution at a dose of 2.0 mg moxidectin + 40 mg fluralaner/kg bodyweight reliably prevents cat aelurostrongylosis for at least 12 weeks.
Identifiants
pubmed: 33593394
doi: 10.1186/s13071-021-04610-y
pii: 10.1186/s13071-021-04610-y
pmc: PMC7885211
doi:
Substances chimiques
A1443 compound
0
Anthelmintics
0
Isoxazoles
0
Macrolides
0
moxidectin
NGU5H31YO9
Types de publication
Journal Article
Randomized Controlled Trial, Veterinary
Langues
eng
Sous-ensembles de citation
IM
Pagination
110Références
Schnyder M, Di Cesare A, Basso W, Guscetti F, Riond B, Glaus T, et al. Clinical, laboratory and pathological findings in cats experimentally infected with Aelurostrongylus abstrusus. Parasitol Res. 2014;113:1425–33.
pubmed: 24504600
doi: 10.1007/s00436-014-3783-2
Crisi PE, Aste G, Traversa D, Di Cesare A, Febo E, Vignoli M, et al. Single and mixed feline lungworm infections: clinical, radiographic and therapeutic features of 26 cases (2013–2015). J Feline Med Surg. 2017;19:1017–29.
pubmed: 27694367
doi: 10.1177/1098612X16670563
Soares C, Cardoso M, Mestre A, Crisi PE. Case report: Severe and progressive bronchopneumonia by Aelurostrongylus abstrusus in an adopted stray cat from Portugal. J Parasit Dis. 2017;41:976–80.
pubmed: 29114129
pmcid: 5660021
doi: 10.1007/s12639-017-0921-7
Philbey AW, Krause S, Jefferies R. Verminous pneumonia and enteritis due to hyperinfection with Aelurostrongylus abstrusus in a kitten. J Comp Pathol. 2014;150:357–60.
pubmed: 24679855
doi: 10.1016/j.jcpa.2014.02.001
Kiszely S, Gyurkovszky M, Solymosi N, Farkas R. Survey of lungworm infection of domestic cats in Hungary. Acta Vet Hung. 2019;67:407–17.
pubmed: 31549542
doi: 10.1556/004.2019.041
Traversa D, Di Cesare A, Milillo P, Lohr B, Iorio R, Pampurini F, et al. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline aelurostrongylosis. Parasitol Res. 2009;105(Suppl 1):55–62.
doi: 10.1007/s00436-009-1496-8
Hobmaier M, Hobmaier A. Mammalian phase of the lung-worm Aelurostrongylus abstrusus in the cat. J Am Vet Med Assoc. 1935;87:191–8.
Jezewski W, Bunkowska-Gawlik K, Hildebrand J, Perec-Matysiak A, Laskowski Z. Intermediate and paratenic hosts in the life cycle of Aelurostrongylus abstrusus in natural environment. Vet Parasitology. 2013;198:401–5.
doi: 10.1016/j.vetpar.2013.09.003
Grandi G, Comin A, Ibrahim O, Schaper R, Forshell U, Lind EO. Prevalence of helminth and coccidian parasites in Swedish outdoor cats and the first report of Aelurostrongylus abstrusus in Sweden: a coprological investigation. Acta Vet Scand. 2017;59:19.
pubmed: 28330485
pmcid: 5362991
doi: 10.1186/s13028-017-0287-y
Elsheikha HM, Wright I, Wang B, Schaper R. Prevalence of feline lungworm Aelurostrongylus abstrusus in England. Vet Parasitology Reg Stud Rep. 2019;16:100271.
Garcia-Campos A, Power C, O’Shaughnessy J, Browne C, Lawlor A, McCarthy G, et al. One-year parasitological screening of stray dogs and cats in County Dublin. Ireland Parasitology. 2018;9:1–7.
Zottler EM, Bieri M, Basso W, Schnyder M. Intestinal parasites and lungworms in stray, shelter and privately owned cats of Switzerland. Parasitol Int. 2019;69:75–81.
pubmed: 30552978
doi: 10.1016/j.parint.2018.12.005
Gueldner EK, Gilli U, Strube C, Schnyder M. Seroprevalence, biogeographic distribution and risk factors for Aelurostrongylus abstrusus infections in Swiss cats. Vet Parasitol. 2019;266:27–33.
pubmed: 30736945
doi: 10.1016/j.vetpar.2018.12.013
Raue K, Heuer L, Böhm C, Wolken S, Epe C, Strube C. 10-year parasitological examination results (2003 to 2012) of faecal samples from horses, ruminants, pigs, dogs, cats, rabbits and hedgehogs. Parasitol Res. 2017;116:3315–30.
pubmed: 29027596
doi: 10.1007/s00436-017-5646-0
Hansen AP, Skarbye LK, Vinther LM, Willesen JL, Pipper CB, Olsen CS, et al. Occurrence and clinical significance of Aelurostrongylus abstrusus and other endoparasites in Danish cats. Vet Parasitol. 2017;234:31–9.
pubmed: 28115180
doi: 10.1016/j.vetpar.2016.12.015
Olsen CS, Willesen JL, Pipper CB, Mejer H. Occurrence of Aelurostrongylus abstrusus (Railliet, 1898) in Danish cats: A modified lung digestion method for isolating adult worms. Vet Parasitol. 2015;210:32–9.
pubmed: 25858114
doi: 10.1016/j.vetpar.2015.03.016
Diakou A, Di Cesare A, Barros LA, Morelli S, Halos L, Beugnet F, et al. Occurrence of Aelurostrongylus abstrusus and Troglostrongylus brevior in domestic cats in Greece. Parasit Vectors. 2015;8:590.
pubmed: 26577206
pmcid: 4650351
doi: 10.1186/s13071-015-1200-z
Morelli S, Diakou A, Di Cesare A, Schnyder M, Colombo M, Strube C, et al. Feline lungworms in Greece: copromicroscopic, molecular and serological study. Parasitol Research. 2020;119:2877–83.
doi: 10.1007/s00436-020-06839-5
Giannelli A, Capelli G, Joachim A, Hinney B, Losson B, Kirkova Z, et al. Lungworms and gastrointestinal parasites of domestic cats: a European perspective. Int J Parasitol. 2017;47:517–28.
pubmed: 28455237
doi: 10.1016/j.ijpara.2017.02.003
Di Cesare A, Gueldner EK, Traversa D, Veronesi F, Morelli S, Crisi PE, et al. Seroprevalence of antibodies against the cat lungworm Aelurostrongylus abstrusus in cats from endemic areas of Italy. Vet Parasitol. 2019;272:13–6.
pubmed: 31395199
doi: 10.1016/j.vetpar.2019.06.017
Abu-Madi MA, Al-Ahbabi DA, Al-Mashhadani MM, Al-Ibrahim R, Pal P, Lewis JW. Patterns of parasitic infections in faecal samples from stray cat populations in Qatar. J Helminthol. 2007;81:281–6.
pubmed: 17875227
doi: 10.1017/S0022149X07818505
Sommerfelt IE, Cardillo N, Lopez C, Ribicich M, Gallo C, Franco A. Prevalence of Toxocara cati and other parasites in cats’ faeces collected from the open spaces of public institutions: Buenos Aires. Argentina Vet Parasitol. 2006;140:296–301.
pubmed: 16647819
doi: 10.1016/j.vetpar.2006.03.022
Carruth AJ, Buch JS, Braff JC, Chandrashekar R, Bowman DD. Distribution of the feline lungworm Aelurostrongylus abstrusus in the USA based on fecal testing. JFMS Open Rep. 2019;5:2055116919869053.
pubmed: 31523446
pmcid: 6727092
Adams PJ, Elliot AD, Algar D, Brazell RI. Gastrointestinal parasites of feral cats from Christmas Island. Aust Vet J. 2008;86:60–3.
pubmed: 18271830
doi: 10.1111/j.1751-0813.2007.00246.x
Cavalera MA, Schnyder M, Gueldner EK, Furlanello T, Iatta R, Brianti E, et al. Serological survey and risk factors of Aelurostrongylus abstrusus infection among owned cats in Italy. Parasitol Res. 2019;118:2377–82.
pubmed: 31230159
doi: 10.1007/s00436-019-06373-z
Zottler EM, Strube C, Schnyder M. Detection of specific antibodies in cats infected with the lung nematode Aelurostrongylus abstrusus. Vet Parasitol. 2017;235:75–82.
pubmed: 28215872
doi: 10.1016/j.vetpar.2017.01.015
Abbate JM, Arfuso F, Gaglio G, Napoli E, Cavalera MA, Giannetto S, et al. Larval survival of Aelurostrongylus abstrusus lungworm in cat litters. J F Med Surg. 2019;21:992–7.
doi: 10.1177/1098612X18811168
von Holtum C, Strube C, Schnieder T, von Samson-Himmelstjerna G. Development and evaluation of a recombinant antigen-based ELISA for serodiagnosis of cattle lungworm. Vet Parasitol. 2008;151:218–26.
doi: 10.1016/j.vetpar.2007.11.006
Pennisi MG, Hartmann K, Addie DD, Boucraut-Baralon C, Egberink H, Frymus T, et al. Lungworm disease in cats: ABCD guidelines on prevention and management. J F Med Surg. 2015;17:626–36.
doi: 10.1177/1098612X15588455
Traversa D, Di Cesare A. Diagnosis and management of lungworm infections in cats: Cornerstones, dilemmas and new avenues. J F Med Surg. 2016;18:7–20.
doi: 10.1177/1098612X15623113
Hamilton JM. The influence of infestation by Aelurostrongylus abstrusus on the pulmonary vasculature of the cat. Br Vet J. 1970;126:202–9.
pubmed: 5448137
doi: 10.1016/S0007-1935(17)48423-5
Knaus M, Chester ST, Rosentel J, Kühnert A, Rehbein S. Efficacy of a novel topical combination of fipronil, (S)-methoprene, eprinomectin and praziquantel against larval and adult stages of the cat lungworm Aelurostrongylus abstrusus. Vet Parasitol. 2014;202:64–8.
pubmed: 24703080
doi: 10.1016/j.vetpar.2014.02.042
Heuer L, Petry G, Pollmeier M, Schaper R, Deuster K, Schmidt H, et al. Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis. Parasit Vectors. 2020;13:65.
pubmed: 32051008
pmcid: 7017503
doi: 10.1186/s13071-020-3937-2
VICH Guideline 9: Good Clinical Practice. Veterinary International Cooperation on Harmonization, European Agency for the Evaluation of Medical Products, London, CVMP/VICH/595/98-Final, 2000.
VICH Guideline 7: Efficacy of Anthelmintics: General Requirements., Veterinary International Cooperation on Harmonization, European Agency for the Evaluation of Medical Products, London, CVMP/VICH/832/99-corr. 2000.
Di Cesare A, Crisi PE, Di Giulio E, Veronesi F, FrangipanediRegalbono A, Talone T, et al. Larval development of the feline lungworm Aelurostrongylus abstrusus in Helix aspersa. Parasitol Res. 2013;112:3101–8.
pubmed: 23743614
doi: 10.1007/s00436-013-3484-2
Di Cesare A, Veronesi F, FrangipanediRegalbono A, Iorio R, Traversa D. Novel Molecular Assay for Simultaneous Identification of Neglected Lungworms and Heartworms Affecting Cats. J Clin Microbiol. 2015;53:3009–13.
pubmed: 26109447
pmcid: 4540927
doi: 10.1128/JCM.00901-15
Morelli S, Traversa D, Colombo M, Raue K, Strube C, Pollmeier M, et al. The effect of the hibernation on the larval development of Troglostrongylus brevior in the land snail Cornu aspersum. Vet Parasitol. 2020;282:109123.
pubmed: 32416560
doi: 10.1016/j.vetpar.2020.109123
Gerichter CB. Studies on the nematodes parasitic in the lungs of Felidae in Palestine. Parasitology. 1949;39:251–62.
pubmed: 18112008
doi: 10.1017/S0031182000083827
Böhm C, Wolken S, Schnyder M, Basso W, Deplazes P, Di Cesare A, et al. Efficacy of Emodepside/Praziquantel Spot-on (Profender®) against adult Aelurostrongylus abstrusus Nematodes in Experimentally Infected Cats. Parasitol Res. 2015;114(Suppl 1):S155–64.
pubmed: 26152416
doi: 10.1007/s00436-015-4521-0
Gould RJ, Fioravanti C, Cook PG, Solomon HF. A model of gastric emptying in cats shows solid emptying is promoted by MK-329: a CCK antagonist. J Nucl Med. 1990;31:1494–9.
pubmed: 2203881
Husnik R, Gaschen FP, Fletcher JM, Gaschen L. Ultrasonographic assessment of the effect of metoclopramide, erythromycin, and exenatide on solid-phase gastric emptying in healthy cats. J Vet Intern Med. 2020;34:99.
doi: 10.1111/jvim.15787
Helps CR, Lait P, Damhuis A, Björnehammar U, Bolta D, Brovida C, et al. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Vet Rec. 2005;156:669–73.
pubmed: 15908495
doi: 10.1136/vr.156.21.669
Gerdin JA, Slater MR, Makolinski KV, Looney AL, Appel LD, Martin NM, et al. Post-mortem findings in 54 cases of anesthetic associated death in cats from two spay-neuter programs in New York State. J F Med Sur. 2011;13:959–66.
doi: 10.1016/j.jfms.2011.07.021
Cavalera MA, Colella V, Napoli E, Arfuso F, Panarese R, Brianti E, et al. Shedding of feline lungworm larvae and their infectivity to snail intermediate hosts after anthelmintic treatment. Int J Parasitol. 2019;49:449–53.
pubmed: 30904621
doi: 10.1016/j.ijpara.2018.12.008
ESCCAP. Worm control in dogs and cats. ESCCAP guideline 01, sixth edition. 2020. https://www.esccap.org/link-document/27/ . Accessed 10 Nov 2020.
ESCCAP Deutschland. Bekämpfung von Würmern (Helminthen) bei Hunden und Katzen. Deutsche Adaption der ESCCAP-Empfehlung Nr. 1. 2014. https://www.esccap.de/v2/wp-content/uploads/2020/06/2018-ESCCAP-Helminthen_01.pdf . Accessed 10 Nov 2020.